Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Dec:27:10760296211020833.
doi: 10.1177/10760296211020833.

Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19

Beuy Joob  1 , Viroj Wiwanitkit  2
Affiliations

Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19

Beuy Joob et al. Clin Appl Thromb Hemost. 2021 Jan-Dec.
No abstract available

Keywords: COVID-19; vaccine; viscosity.

PubMed Disclaimer

Comment in

References

    1. Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021;372:n699. - PubMed
    1. Wiwanitkit V. COVID-19 vaccine, immune response, previous asymptomatic infection and blood clots. 2021. Accessed June 8, 2021. https://www.bmj.com/content/372/bmj.n699/rr-2
    1. Saadat S, Tehrani ZR, Logue J, et al. Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2. JAMA. 2021;325(14):1467–1469. doi:10.1001/jama.2021.3341 - PMC - PubMed
    1. Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44(2):223–226. - PubMed
    1. Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost. 2003;29(5):467–471. - PubMed